* In vitro studies using advanced imaging techniques demonstrated that PDMA-b-PNIPAM significantly boosts the internalization of these nanoparticles in human colon (HCT-116) and bladder (T24) cancer cells.
* The encapsulation of the chemotherapy drug camptothecin (CPT) within PDMA-b-PNIPAM-stabilized nanoparticles increased treatment efficacy, explained by the stabilizer's higher lipophilicity and its improved interaction with cell membranes.